Introduction Toxin screening plays a crucial role in evaluating patients with early Alzheimer’s Dementia (AD) or Mild Cognitive Impairment (MCI). Below is a detailed overview of the types, roles, and rationale for toxin screening in this context: Heavy Metal Testing Rationale: Heavy metals can accumulate in brain tissue, leading to oxidative stress, inflammation, and neuronal damage.… Continue reading Toxicity Testing and Assessment for Early Alzheimers and Mild Cognitive Impairment
Tag: Dementia Testing
Infectious Contributors to Alzheimer’s Dementia
Understanding the Role of Infections, Oral Health, and Gut Health in Alzheimer’s Disease Alzheimer’s disease (AD) is a complex condition influenced by a variety of factors, including infections, gut health, and gum disease. Emerging research demonstrates strong links between these contributors, neuroinflammation, and the onset of dementia. 1. Chronic Infections and Brain Health Certain infections… Continue reading Infectious Contributors to Alzheimer’s Dementia
Comprehensive Testing for Early Alzheimers and Mild Cognitive Impairment
Introduction Inspired by the innovative work of Dr. Dale Bredesen, our approach to supporting our patients with Alzheimer’s Dementia or Mild Cognitive Impairment (MCI), emphasizes a comprehensive assessment for the many potential contributors. It’s important to know that cognitive decline is not a given with aging. With early detection and a well-rounded treatment plan, there… Continue reading Comprehensive Testing for Early Alzheimers and Mild Cognitive Impairment